CRYO-CELL INTERNATIONAL, INC. Federal Income Tax Expense (Benefit), Continuing Operations
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Federal Income Tax Expense (Benefit), Continuing Operations of $4.59 million for the 12-month period ending 2025-11-30, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-02-27
- CRYO-CELL INTERNATIONAL, INC. federal income tax expense (benefit), continuing operations for fiscal 2025 was $4.59M, a 69.12% increase from fiscal 2024.
- CRYO-CELL INTERNATIONAL, INC. federal income tax expense (benefit), continuing operations for fiscal 2024 was $2.72M, a 49.20% increase from fiscal 2023.
- CRYO-CELL INTERNATIONAL, INC. federal income tax expense (benefit), continuing operations for fiscal 2023 was $1.82M, a 15.77% increase from fiscal 2022.
- CRYO-CELL INTERNATIONAL, INC. federal income tax expense (benefit), continuing operations for fiscal 2022 was $1.57M, a 55.48% decline from fiscal 2021.
| Period end | Federal Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2025-11-30 | $4.59M 10-K · filed 2026-02-27 |
| 2024-11-30 | $2.72M 10-K · filed 2026-02-27 |
| 2023-11-30 | $1.82M 10-K · filed 2025-02-28 |
| 2022-11-30 | $1.57M 10-K · filed 2024-02-28 |
| 2021-11-30 | $3.53M 10-K · filed 2023-02-28 |
| 2020-11-30 | $1.88M 10-K · filed 2022-02-22 |
| 2019-11-30 | $2.80M 10-K · filed 2021-03-01 |
| 2018-11-30 | $2.20M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |